SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-017429
Filing Date
2023-05-15
Accepted
2023-05-15 16:30:28
Documents
33
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 475033
2 ex31-1.htm EX-31.1 17330
3 ex31-2.htm EX-31.2 16999
4 ex32-1.htm EX-32.1 7644
  Complete submission text file 0001493152-23-017429.txt   1992256

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE vblt-20230331.xsd EX-101.SCH 16168
6 XBRL CALCULATION FILE vblt-20230331_cal.xml EX-101.CAL 28186
7 XBRL DEFINITION FILE vblt-20230331_def.xml EX-101.DEF 52371
8 XBRL LABEL FILE vblt-20230331_lab.xml EX-101.LAB 164838
9 XBRL PRESENTATION FILE vblt-20230331_pre.xml EX-101.PRE 115510
27 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 117286
Mailing Address HASATAT 8 ST. MODI'IN, L3 7178106
Business Address HASATAT 8 ST. MODI'IN, L3 7178106 972-3-6346450
Vascular Biogenics Ltd. (Filer) CIK: 0001603207 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36581 | Film No.: 23923103
SIC: 2834 Pharmaceutical Preparations